The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Long-term income investors can find the middle ground with a 3.4% yield and a 45% payout ratio from Merck. 10 stocks we like better than Merck › Dividend investors need to be cautious about reaching too far for yield since this can open them up to added risks. At the same time, they must ensure that they are generating an attractive enough income stream to make the investment worthwhile. One pharmaceutical stock stands out to income seekers today with its balance between risk and reward. Investors looking for the best-performing pharmaceutical company today will probably be drawn to Eli Lilly (NYSE: LLY) . The company's GLP-1 weight-loss drugs are smashing it, with Mounjaro sales up 109% year over year in the third quarter of 2025 and Zepbound sales higher by an even larger 185%. There's just one problem: Investors are well aware of the company's success. Eli Lilly's dividend payout ratio is a very reasonable 30% or so. The company is likely to be a reliable dividend payer, e
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Drug Delivery Devices Market Set to Exceed US$ 450.7 Billion by 2035 as Biologic Revenue Surges Drive Urgent Expansion of Device Manufacturing Capacity Says Astute Analytica [Yahoo! Finance]Yahoo! Finance
- MEDI&GENE Announces Catalyze Agreement with Lilly to Advance Next-Generation Obesity Therapeutics [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Daiwa America from a "hold" rating to a "strong-buy" rating.MarketBeat
- Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly [CNBC]CNBC
- Is Eli Lilly a Buy Before 2026? [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 12/16/25 - Form 4
- 12/16/25 - Form 4
- 12/16/25 - Form 4
- LLY's page on the SEC website